Abstract
The purpose of our paper was to evaluate the performance of ultrasound (US) for assessment of the severity of liver steatosis as compared to a pathological examination, which is presently considered to be the gold standard, in patients that have undergone liver biopsy for various reasons. We performed echo-assisted liver biopsy in 161 patients with chronic hepatitis with the US aspect of “bright liver” with “posterior attenuation”, using modified Menghini needles. Following the US examination, the severity of liver steatosis was estimated as minimal, mild, moderate. or severe according to the Hepburn classification: absent (affecting 0% to 2% of the hepatocytes), minimal (2% to 10%), mild (10% to 30%), moderate (30% to 60%), and severe (more than 60% of the hepatocytes). The results of this study showed that the sensitivity of US for the prediction of histological steatosis of at least moderate severity was 0.64, with 0.77 specificity, 0.55 positive predictive value, and 0.94 negative predictive value. The overall accuracy was 0.75. This study showed that the transabdominal ultrasound evaluation of the fatty liver is a quite good predictor, perhaps sufficient for most purposes, for the estimation of the severity of liver steatosis in the moderate to severe range.
[1] Zelber-Sagi S., Nitzan-Kaluski D., Halpern Z., Oren R., Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures., Liver International, 2006, 26, 856–863 http://dx.doi.org/10.1111/j.1478-3231.2006.01311.x10.1111/j.1478-3231.2006.01311.xSearch in Google Scholar
[2] Abdelmalek M.F., Diehl A.M., Nonalcoholic fatty liver disease as a complication of insulin resistance., Med. Clin. North. Am., 2007, 91(6),1125–1149 http://dx.doi.org/10.1016/j.mcna.2007.06.00110.1016/j.mcna.2007.06.001Search in Google Scholar
[3] Bedogni G., Bellentani S., Fatty liver, how frequent is it and why?, Ann. Hepatol., 2004, 3, 63–65 10.1016/S1665-2681(19)32110-6Search in Google Scholar
[4] Negro F., Insulin resistance and HCV, will new knowledge modify clinical management?, Journal of Hepatology, 2006, 45, 514–519 http://dx.doi.org/10.1016/j.jhep.2006.07.01110.1016/j.jhep.2006.07.011Search in Google Scholar
[5] Falck-Ytter Y., Younossi Z.M., Marchesini G., McCullough A.J., Clinical feature and natural history of nonalcoholic steatosis syndromes., Semin. Liver. Dis., 2001, 21, 17–26 http://dx.doi.org/10.1055/s-2001-1292610.1055/s-2001-12926Search in Google Scholar
[6] Ratziu V., Giral.P, Charlotte F., Bruckert E., Thibault V., Theodorou I. et al, Liver fibrosis in overweight patients., Gastroenterology, 2000, 118, 1117–1123 http://dx.doi.org/10.1016/S0016-5085(00)70364-710.1016/S0016-5085(00)70364-7Search in Google Scholar
[7] Adams L.A., Lymp J.F., Sauver J., Sanderson S.O., Lindor K.D., Feldstein A. et al, The natural history of nonalcoholic fatty liver disease, a population-based cohort study., Gastroenterology, 2005, 129, 113–121 http://dx.doi.org/10.1053/j.gastro.2005.04.01410.1053/j.gastro.2005.04.014Search in Google Scholar PubMed
[8] Munteanu M., Ratziu V., Morra R., Messous D., Imbert-Bismut F., Poynard T., Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience., J. Gastrointestin Liver Dis., 2008, 17(2), 187–191 Search in Google Scholar
[9] Lydatakis H., Hager I.-P., Kostadelou E., Mpousmpoulas S., Pappas S., Diamantis I., Noninvasive markers to predict the liver fibrosis in nonalcoholic fatty liver disease., Liver International, 2006, 26, 864–871 http://dx.doi.org/10.1111/j.1478-3231.2006.01312.x10.1111/j.1478-3231.2006.01312.xSearch in Google Scholar PubMed
[10] Sanyal A.J., AGA technical review on nonalcoholic fatty liver disease., Gastroenterology 2002, 123, 1705–1725 http://dx.doi.org/10.1053/gast.2002.3657210.1053/gast.2002.36572Search in Google Scholar PubMed
[11] Tobari M., Hashimoto E., Yatsuji S., Torii N., Taniai M., Tokushige K. et al, The usefulness of ultrasonography and computerized tomography in imaging of nonalcoholic steatohepatitis., Hepatology, 2006, 44(S1), 658A Search in Google Scholar
[12] Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C. et al, Prevalence of hepatic steatosis in an urban population in United States: impact of ethnicity., Hepatology, 2004, 40, 1387–1395 http://dx.doi.org/10.1002/hep.2046610.1002/hep.20466Search in Google Scholar PubMed
[13] Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J., Nonalcoholic fatty liver disease, a spectrum of clinical and pathological severity., Gastroenterology, 1999, 116, 1413–1419 http://dx.doi.org/10.1016/S0016-5085(99)70506-810.1016/S0016-5085(99)70506-8Search in Google Scholar
[14] Al Knawy B., Shiffman M., Percutaneous liver biopsy in clinical practice., Liver Int. 2007, 27(9), 1166–1173 http://dx.doi.org/10.1111/j.1478-3231.2007.01592.x10.1111/j.1478-3231.2007.01592.xSearch in Google Scholar
[15] Hepburn J.M., Vos J.A., Fillman E.P., Lawitz E.J., The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: A retrospective observational study., BMC Gastroenterol., 2005, 5, 14–28 http://dx.doi.org/10.1186/1471-230X-5-1410.1186/1471-230X-5-14Search in Google Scholar
[16] Palmentieri B., de Sio I., La Mura V., Masarone M., Vecchione R., Bruno S. et al, The role of liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis., Dig. Liver. Dis., 2006, 38, 485–489 http://dx.doi.org/10.1016/j.dld.2006.03.02110.1016/j.dld.2006.03.021Search in Google Scholar
[17] Mathiesen U.L., Franzen L.E., Aselius H., Resjö M., Jacobsson L., Foberg U. et al, Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases., Dig. Liver. Dis., 2002, 34, 516–522 http://dx.doi.org/10.1016/S1590-8658(02)80111-610.1016/S1590-8658(02)80111-6Search in Google Scholar
[18] Fishbein M., Castro F., Cheruku S., Jain S., Webb B., Gleason T. et al, Hepatic MRI for fat quantification, its relationship to fat morphology, diagnosis and ultrasound., J. Clin. Gastroenterol., 2005, 39, 619–625 http://dx.doi.org/10.1097/00004836-200508000-0001210.1097/00004836-200508000-00012Search in Google Scholar
[19] Kim S.H., Lee J.M., Kim J.M., Kim K.G., Han J.K., Lee K.H. et al, Appropriateness of a donor liver with respect to macrosteatosis, application of artificial neural networks to US images- initial experience., Radiology, 2005, 234, 793–803 http://dx.doi.org/10.1148/radiol.234304014210.1148/radiol.2343040142Search in Google Scholar
[20] Gaitini D., Lederman M., Baruch Y., Ghersin E., Veitsman E., Kerner H. et al, Computerized analysis of liver texture with correlation to needle biopsy., European J. Ultrasound 2005, 26, 197–202 10.1055/s-2005-858267Search in Google Scholar
[21] Ataseven H., Yildirim M.H., Yalniz M., Bahcecioglu I.H., Celebi S., Ozercan I.H., The value of ultrasonography and computerized tomography in estimating the histopathological severity of nonalcoholic steatohepatitis., Acta Gastroenterol. Belg., 2005, 68, 221–225 Search in Google Scholar
[22] Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M. et al, The utility of radiological imaging in nonalcoholic fatty liver disease., Gastroenterology 2002, 123, 745–750 http://dx.doi.org/10.1053/gast.2002.3535410.1053/gast.2002.35354Search in Google Scholar
[23] Joseph A.E., Saverymuttu S.H., al-Sam S., Cook M.G., Maxwell J.D., Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease., Clin. Radiol., 1991, 43, 26–31 http://dx.doi.org/10.1016/S0009-9260(05)80350-210.1016/S0009-9260(05)80350-2Search in Google Scholar
© 2009 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
